News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Virogen, Inc. Receives Purchase Orders Totaling $400,000


11/6/2008 9:05:47 AM

MINNEAPOLIS, MN--(Marketwire - November 06, 2008) - Virogen, Inc. (PINKSHEETS: VRGI), the developer and patent holder of a revolutionary vaccine to combat Newcastle disease, a deadly disease that kills chickens worldwide, reports that it has received purchase orders totaling $400,000 from its Asian and Middle Eastern distributors. This is truly a milestone for Virogen taking the company from its longstanding R&D phase to become a fully functional commercial enterprise. As anticipated, this purchase order follows shortly after receipt of VRGI's European Union (EU) manufacturing approval and licensing.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES